In the News

Fighting diabetes one kick at a time
By JDRF Canada
August 29, 2014

Sun Life Financial and the Canadian Football League (CFL) partner to raise up to $100,000 for JDRF

Read More
Tags: Sun Life, JDRF, type 1 diabetes, CFL, Kick Diabetes Program, Prevention, T1D, Corporate Partnerships, football
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial
By JDRFI
August 21, 2014

JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate.

Read More
Tags: ViaCyte, Type 1 Diabetes Clinical Trials, clinical trial, VC-01, encapsulated cell replacement therapy
JDRF Partner ViaCyte Announces Key Project Milestone
By JDRFI
July 18, 2014

JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes

Read More
Tags: JDRF, Novo Nordisk, Performance in Exercise and Knowledge (PEAK), Outreach, grant
Novo Nordisk Commits $5 Million Grant Supporting JDRF Outreach Initiative
By JDRFI
July 14, 2014

To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Knowledge (PEAK)”.

Read More
Tags: JDRF, Novo Nordisk, Performance in Exercise and Knowledge (PEAK), Outreach, grant
JDRF and the Innovative Medicines Initiative Partner for Type 1 Diabetes Research
By JDRFI
July 14, 2014

JDRF and the Innovative Medicines Initiative (IMI) have partnered on a new precompetitive type 1 diabetes research consortium entitled “TRANSLATIONAL APPROACHES TO DISEASE MODIFYING THERAPY OF TYPE 1 DIABETES MELLITUS (T1DM)”. 

Read More